SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $883,276 | -86.1% | 38,204 | -84.3% | 0.00% | -100.0% |
| Q2 2023 | $6,365,220 | +354.2% | 242,762 | +345.9% | 0.00% | +100.0% |
| Q1 2023 | $1,401,491 | +156.2% | 54,448 | +145.3% | 0.00% | – |
| Q2 2022 | $547,000 | -78.9% | 22,196 | -51.7% | 0.00% | -100.0% |
| Q1 2022 | $2,595,000 | +132.9% | 45,969 | +155.8% | 0.00% | – |
| Q4 2021 | $1,114,000 | -15.9% | 17,974 | -13.9% | 0.00% | – |
| Q3 2021 | $1,324,000 | -2.8% | 20,866 | -27.0% | 0.00% | -100.0% |
| Q3 2020 | $1,362,000 | +273.2% | 28,573 | +228.6% | 0.00% | – |
| Q2 2020 | $365,000 | +18.9% | 8,695 | -38.5% | 0.00% | -100.0% |
| Q3 2019 | $307,000 | – | 14,142 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |